Clinical Trials Directory

Trials / Completed

CompletedNCT04632641

Suture Closure AFtEr VEIN Access for Cardiac Procedures (SAFE-VEIN) Trial

Suture Closure AFtEr VEIN Access for Cardiac Procedures (SAFE-VEIN) Trial: A Randomized, Prospective Study of the Safety and Efficacy of Venous Closure Device Compared to Conventional Closure Strategies in Post Venous Access Procedures

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
107 (actual)
Sponsor
Wake Forest University Health Sciences · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Primary objective: To compare the safety and efficacy of closure strategies post venous access procedures. Hypothesis: We anticipate that the use of a venous closure device will decrease the time to hemostasis (TTH), time to ambulation (TTA) and time to discharge (TTD) compared to conventional methods of closure following venous access procedure.

Detailed description

This study will be a prospective, randomized study of patients who are undergoing one or more of the following procedures at ASLMC (Aurora St. Luke's Medical Center): Large-Bore Procedures \>13 F 1. WATCHMAN® device placement 2. Atrial fibrillation/flutter/SVT (supraventricular tachycardia) ablation using cryoballoon or laser balloon 3. Leadless pacemaker 4. Pulmonary embolism thrombectomy (Inari FlowTriever system) 5. MitraClip transcatheter mitral valve repair RANDOMIZATION: Patients will be randomized into one of two venous closure groups after a clean stick has been achieved with no complications: Large-bore (14F-25F) venous access group (1:1) * Perclose ProGlide SMC * Figure 8 suture

Conditions

Interventions

TypeNameDescription
DEVICEPerclose ProGlide Suture-Mediated Closure System (SMC) - LARGE-BORE PROCEDURESThe Perclose ProGlide Suture-Mediated Closure System (SMC) will be used to close the vein access site(s) at the completion of the large-bore procedure in order to achieve hemostasis.
OTHERFigure 8 Suture - LARGE-BORE PROCEDURESA figure 8 suture will be done as a closure strategy in order to achieve hemostasis in large-bore procedures.

Timeline

Start date
2021-04-23
Primary completion
2022-12-31
Completion
2023-12-31
First posted
2020-11-17
Last updated
2024-10-03
Results posted
2024-05-16

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04632641. Inclusion in this directory is not an endorsement.